A Phase 1b Study of WU-NK-101 in Combination With Cetuximab for Advanced and/or Metastatic Colorectal Cancer (CRC) and Advanced and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Disease Name: 
Metastatic Colorectal Cancer
Squamous Cell Carcinoma of the Head and Neck
Study Status: 
Date: 
July 19, 2024